NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1023123288 MD
Verify on CMS → Syed Ahmed, MD
Hematology & Oncology Physician in El Centro, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
933
Medicare Part D claims · 191 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
26.5/100
▼ 57 pts below national avg 83.5 · Below average
Industry payments
$827.19
36 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Syed Ahmed, MD reported a CMS MIPS final score of 26.5/100 - below the 83.5 national average - and filed 933 Medicare Part D claims in 2024.
- 26.5/100
- MIPS score · -57 vs avg
- 933
- Part D claims, 2024
- 68%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Syed Ahmed, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1023123288), first enumerated 08/20/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 933 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 26.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$827.19 in reported industry payments (36 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Syed Ahmed, MD's individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1023123288 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1023123288
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- MIPS-LOW 26.5/100
- RX-LIGHT 933
- BOOK-LIGHT 1,306 in California
- PHOTO-FINISH Ikenna Osuorji, MD · ±0.7
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Mohammad Khan, M…
Mohammad Khan, MD
24.9 MIPS pts
- Ahmed · this pro…
Ahmed · this provider
26.5 MIPS pts
- Ikenna Osuorji, …
Ikenna Osuorji, MD
27.2 MIPS pts
- Manjeet Chawla, …
Manjeet Chawla, MD
27.3 MIPS pts
- Carol Bogdan, MD…
Carol Bogdan, MD
28 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Syed Ahmed, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
27 ≥ 3rd percentile 3% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Syed Ahmed, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Syed Ahmed, MD writes more Part D claims than 60% of them and scores higher on MIPS quality than 1% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Syed Ahmed, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Syed Ahmed, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Syed Ahmed, MD?
Below national averagePrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
933 5% vs specialty avg
MIPS final score
26.5/100 57 pts vs avg
Specialty distribution in California
How Hematology & Oncology Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Syed Ahmed, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 26.5/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1023123288 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/20/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
26.5165
Final Score
Measured-score avg: 83.5
30
Quality
15.055
Cost
Reporting: Individual
Hospital and facility affiliations
Facilities where Syed Ahmed, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
S H Ahmed MD Phd Inc
El Centro, CA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Syed Ahmed, MD. Source: openpaymentsdata.cms.gov.
Total received
$827
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Syed Ahmed, MD. To verify Syed Ahmed, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Syed Ahmed, MD - brand share 32.0%
Hematology & Oncology Physician average
32% brand-name claims vs 68% generic, on 933 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
933
Total Claims
$4.9M
Total Drug Cost
191
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,245.267
- Total Day Supply
- 33,121
- Brand vs Generic
- 32% brand / 68% generic
- Brand Drug Cost
- $4.8M
- Generic Drug Cost
- $70K
- Opioid Claims
- 25 (2.7% rate)
- Antibiotic Claims
- 48
Patient Demographics
- Average Patient Age
- 72.8 years
- Avg HCC Risk Score
- 2.82
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 13, 65-74: 105, 75-84: 57, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Syed Ahmed, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Anastrozole
Anastrozole
123 claims
- Xtandi
Xtandi
57 claims
- Letrozole 45
Letrozole
45 claims
- Prednisone 44
Prednisone
44 claims
- Ondansetron Hcl 43
Ondansetron Hcl
43 claims
- Tamoxifen Citrate 43
Tamoxifen Citrate
43 claims
- Prochlorperazine M… 40
Prochlorperazine Maleate
40 claims
- Hydroxyurea 38
Hydroxyurea
38 claims
| Drug | Claims |
|---|---|
| Anastrozole | 123 |
| Xtandi Enzalutamide | 57 |
| Letrozole | 45 |
| Prednisone | 44 |
| Ondansetron Hcl | 43 |
| Tamoxifen Citrate | 43 |
| Prochlorperazine Maleate | 40 |
| Hydroxyurea | 38 |
| Promacta Eltrombopag Olamine | 37 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Syed Ahmed, MD fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Syed Ahmed, MD's 933 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ahmed, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (26.5 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Ahmed.
One of 1,306 Hematology & Oncology Physician providers enrolled in California, 5 are shown here.
Dr. Mark Abate
M.D.
Santa Barbara, CA
Dr. Iman Abdalla
MD
Los Angeles, CA
Dr. Nihal Abdulla
MD
Los Alamitos, CA
Dr. Oyewale Abidoye
M.D.
La Jolla, CA
Dr. Mohamad Adada
M.D., PHD
Roseville, CA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Syed Ahmed, MD's specialty? ▼
Syed Ahmed, MD specializes in Hematology & Oncology Physician and practices in El Centro, California. Credentials: MD.
How much does Syed Ahmed, MD prescribe under Medicare Part D? ▼
In 2024, Syed Ahmed, MD wrote 933 Medicare Part D claims totaling $4.9M in drug costs for 191 beneficiaries.
What is Syed Ahmed, MD's Medicare quality score? ▼
Syed Ahmed, MD has a CMS MIPS Final Score of 26.5/100 (Quality: 30, Cost: 15.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Syed Ahmed, MD located? ▼
Syed Ahmed, MD is located at 1271 ROSS AVE, El Centro, CA, 92243. Phone: (760) 335-3030.
What is Syed Ahmed, MD's NPI number? ▼
Syed Ahmed, MD's National Provider Identifier (NPI) is 1023123288, issued on 08/20/2006.
Does Syed Ahmed, MD prescribe more brand-name or generic drugs? ▼
Syed Ahmed, MD's prescribing is 32% brand-name and 68% generic drugs by claim count, with $4.8M in brand drug costs.
Does Syed Ahmed, MD prescribe opioids? ▼
Yes, Syed Ahmed, MD had 25 opioid claims in 2024 with an opioid prescribing rate of 2.7%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Syed Ahmed, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Syed Ahmed, MD's most frequently prescribed drugs include Anastrozole, Xtandi, Letrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Syed Ahmed, MD accept Medicare? ▼
Syed Ahmed, MD appears in CMS Medicare data with 933 Part D claims and 191 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Syed Ahmed, MD's credentials? ▼
Syed Ahmed, MD's NPI is 1023123288 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.